These findings align with studies linking low NLR and SII to better outcomes in ICI-treated R/M-HNSCC and non-small cell lung cancer (NSCLC) (22, 23), although some reports on albumin’s predictive role have been inconsistent (24). This evidence concerns the gene ALB and head and neck squamous cell carcinoma.